Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 32685259!7364271!32685259     free     free     free       Am+J+Blood+Res 2020 ; 10 (3): 52-53 Nephropedia Template TP {{tp|p=32685259|t=2020. Risk of COVID-19 in oncohematological patients |pdf=|usr=}}{{32685259}} gab.com Text Risk of COVID-19 in oncohematological patients JO: Am J Blood Res http://www.kidney.de/pget.php?&tw=1&pmid=32685259 #FOAvip As of April 23, 2020, the COVID-19 (SARS-CoV-2) pandemic has affected 2,544,792 people, causing 175,694 deaths worldwide. The global scientific community has turned its attention to the impact of the new virus, which has become a major challenge for healthcare systems in many countries. Oncology patients have been considered of high risk within the ongoing COVID-19 pandemic. Oncology patients are especially vulnerable to infection due to the underlying disease and the type of therapy received. In general, the epidemiologic behavior of community-acquired respiratory viruses among oncology patients resembles that of the general population. Although, at present, there is limited data regarding COVID-19 and solid tumors, oncology patients seem to carry a higher risk of developing severe events. Yet, among patients harboring hematological diseases we have not observed an increase in COVID 19 infections. Twit Text FOAVip Risk of COVID-19 in oncohematological patients ????Am J Blood Res http://www.kidney.de/pget.php?&tw=1&pmid=32685259 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32685259 #FOAvip English Wikipedia <ref>{{Cite pmid|32685259}}</ref> Risk of COVID-19 in oncohematological patients #MMPMID32685259 Alcaraz R; Saiz-Rodriguez M; Cuevas B; Gonzalez-Lopez TJ; Labrador J Am J Blood Res 2020[]; 10 (3): 52-53 PMID32685259show ga As of April 23, 2020, the COVID-19 (SARS-CoV-2) pandemic has affected 2,544,792 people, causing 175,694 deaths worldwide. The global scientific community has turned its attention to the impact of the new virus, which has become a major challenge for healthcare systems in many countries. Oncology patients have been considered of high risk within the ongoing COVID-19 pandemic. Oncology patients are especially vulnerable to infection due to the underlying disease and the type of therapy received. In general, the epidemiologic behavior of community-acquired respiratory viruses among oncology patients resembles that of the general population. Although, at present, there is limited data regarding COVID-19 and solid tumors, oncology patients seem to carry a higher risk of developing severe events. Yet, among patients harboring hematological diseases we have not observed an increase in COVID 19 infections. äRisk of COVID-19 in oncohematological patients (epmc).pdf DeepDyve Pubget Overpricing